BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang X, Lupón J, Vidán MT, Ferguson C, Gastelurrutia P, Newton PJ, Macdonald PS, Bueno H, Bayés-Genís A, Woo J, Fung E. Impact of Frailty on Mortality and Hospitalization in Chronic Heart Failure: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2018;7:e008251. [PMID: 30571603 DOI: 10.1161/JAHA.117.008251] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu E, Lampert BC. Heart Failure in Older Adults: Medical Management and Advanced Therapies. Geriatrics 2022;7:36. [DOI: 10.3390/geriatrics7020036] [Reference Citation Analysis]
2 He Y, Chang J, Wang X. Frailty as a predictor of all-cause mortality in elderly patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis. Archives of Gerontology and Geriatrics 2022;98:104544. [DOI: 10.1016/j.archger.2021.104544] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 De Maria R, Gori M, Marini M, Gonzini L, Benvenuto M, Cassaniti L, Municinò A, Navazio A, Ammirati E, Leonardi G, Pagnoni N, Montagna L, Catalano M, Midi P, Marina Floresta A, Pulignano G, Iacoviello M. Tendencias temporales en las características, tratamiento y resultados de la insuficiencia cardiaca en octogenarios durante dos décadas. Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2022.03.003] [Reference Citation Analysis]
4 Flores-Álvarez FJ, Sillero-Herrera A, Cuesta-Gaviño J, Fernández-Sánchez ML, Vega-Sánchez J, López-Fe JL, Gamboa-Antiñolo FM, Utrilla-Ayala D, Aguirre-Palacio A, De Villar-Conde E, Vergara-López S. Frailty as a predictor of clinical problems and events that require elderly patients with heart failure to use health resources. Arch Gerontol Geriatr 2022;101:104698. [PMID: 35390571 DOI: 10.1016/j.archger.2022.104698] [Reference Citation Analysis]
5 de la Espriella R, Bayés-Genís A, Llàcer P, Palau P, Miñana G, Santas E, Pellicer M, González M, Górriz JL, Bodi V, Sanchis J, Núñez J. Prognostic value of NT-proBNP and CA125 across glomerular filtration rate categories in acute heart failure. Eur J Intern Med 2021:S0953-6205(21)00297-1. [PMID: 34507853 DOI: 10.1016/j.ejim.2021.08.024] [Reference Citation Analysis]
6 Komici K, Gnemmi I, Bencivenga L, Vitale DF, Rengo G, Di Stefano A, Eleuteri E. Impact of Galectin-3 Circulating Levels on Frailty in Elderly Patients with Systolic Heart Failure. J Clin Med 2020;9:E2229. [PMID: 32674344 DOI: 10.3390/jcm9072229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Kałużna-Oleksy M, Kukfisz A, Migaj J, Dudek M, Krysztofiak H, Sawczak F, Szczechla M, Przytarska K, Straburzyńska-Migaj E, Wleklik M, Uchmanowicz I. A Simple Risk Score Based on Routine Clinical Parameters Can Predict Frailty in Hospitalized Heart Failure Patients. J Clin Med 2021;10:5963. [PMID: 34945259 DOI: 10.3390/jcm10245963] [Reference Citation Analysis]
8 Proietti M, Camera M, Gallieni M, Gianturco L, Gidaro A, Piemontese C, Pizzetti G, Redaelli F, Scimeca B, Tadeo CS, Cesari M, Bellelli G, Dalla Vecchia LA. Use and Prescription of Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Multidisciplinary Consensus Document. JPM 2022;12:469. [DOI: 10.3390/jpm12030469] [Reference Citation Analysis]
9 Pandey A, Kitzman D, Reeves G. Frailty Is Intertwined With Heart Failure: Mechanisms, Prevalence, Prognosis, Assessment, and Management. JACC Heart Fail 2019;7:1001-11. [PMID: 31779921 DOI: 10.1016/j.jchf.2019.10.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 15.5] [Reference Citation Analysis]
10 Motta F, Sica A, Selmi C. Frailty in Rheumatic Diseases. Front Immunol 2020;11:576134. [PMID: 33193369 DOI: 10.3389/fimmu.2020.576134] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
11 Fang EF, Xie C, Schenkel JA, Wu C, Long Q, Cui H, Aman Y, Frank J, Liao J, Zou H, Wang NY, Wu J, Liu X, Li T, Fang Y, Niu Z, Yang G, Hong J, Wang Q, Chen G, Li J, Chen HZ, Kang L, Su H, Gilmour BC, Zhu X, Jiang H, He N, Tao J, Leng SX, Tong T, Woo J. A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networks. Ageing Res Rev 2020;64:101174. [PMID: 32971255 DOI: 10.1016/j.arr.2020.101174] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 24.5] [Reference Citation Analysis]
12 Díez-Villanueva P, Jiménez-Méndez C, Alfonso F. Heart failure in the elderly. J Geriatr Cardiol 2021;18:219-32. [PMID: 33907552 DOI: 10.11909/j.issn.1671-5411.2021.03.009] [Reference Citation Analysis]
13 Prichard RA, Zhao FL, Mcdonagh J, Goodall S, Davidson PM, Newton PJ, Farr-Wharton B, Hayward CS. Discrepancies between proxy estimates and patient reported, health related, quality of life: minding the gap between patient and clinician perceptions in heart failure. Qual Life Res 2021;30:1049-59. [PMID: 33387292 DOI: 10.1007/s11136-020-02722-z] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Rivera-Chávez JG, Torres-Gutiérrez JL, Regalado-Villalobos A, Moreno-Cervantes CA, Luna-Torres S. Association between falls and cardiovascular diseases in the geriatric population. Arch Cardiol Mex 2021;91:66-72. [PMID: 33661879 DOI: 10.24875/ACM.20000024] [Reference Citation Analysis]
15 Kanenawa K, Isotani A, Yamaji K, Nakamura M, Tanaka Y, Hirose-Inui K, Fujioka S, Mori S, Yano M, Ito S, Morinaga T, Fukunaga M, Hyodo M, Ando K. The impact of frailty according to Clinical Frailty Scale on clinical outcome in patients with heart failure. ESC Heart Fail 2021;8:1552-61. [PMID: 33547759 DOI: 10.1002/ehf2.13254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Martin AK, Feinman JW, Bhatt HV, Subramani S, Malhotra AK, Townsley MM, Fritz AV, Sharma A, Patel SJ, Zhou EY, Owen RM, Ghofaily LA, Read SN, Teixeira MT, Arora L, Jayaraman AL, Weiner MM, Ramakrishna H. The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights from 2021. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00931-9. [PMID: 34801393 DOI: 10.1053/j.jvca.2021.10.011] [Reference Citation Analysis]
17 Yang Y, Luo K, Jiang Y, Yu Q, Huang X, Wang J, Liu N, Huang P. The Impact of Frailty on COVID-19 Outcomes: A Systematic Review and Meta-analysis of 16 Cohort Studies. J Nutr Health Aging 2021;25:702-9. [PMID: 33949641 DOI: 10.1007/s12603-021-1611-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sunaga A, Hikoso S, Tamaki S, Seo M, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Kurakami H, Yamada T, Kitamura T, Sato T, Oeun B, Kida H, Sotomi Y, Dohi T, Okada K, Mizuno H, Nakatani D, Yamada T, Yasumura Y, Sakata Y, Seo M, Watanabe T, Yamada T, Hayashi T, Higuchi Y, Masuda M, Asai M, Mano T, Fuji H, Masuda D, Tamaki S, Shutta R, Yamashita S, Sairyo M, Nakagawa Y, Abe H, Ueda Y, Matsumura Y, Nagai K, Yano M, Nishino M, Tanouchi J, Arita Y, Ogasawara N, Ishizu T, Ichikawa M, Takano Y, Rin E, Shinoda Y, Tachibana K, Hoshida S, Izumi M, Yamamoto H, Kato H, Nakatani K, Yasuga Y, Nishio M, Hirooka K, Yoshimura T, Yasuoka Y, Tani A, Okumoto Y, Makino Y, Onishi T, Iwakura K, Kijima Y, Kitao T, Kanai H, Fujita M, Harada K, Kumada M, Nakagawa O, Araki R, Yamada T, Nakagawa A, Yasumura Y, Sato T, Sunaga A, Oeun B, Kida H, Sotomi Y, Dohi T, Nakamoto K, Okada K, Sera F, Kioka H, Ohtani T, Takeda T, Nakatani D, Mizuno H, Hikoso S, Sakata Y; OCVC‐Heart Failure Investigators. Association between prognosis and the use of angiotensin‐converting enzyme inhibitors and/or angiotensin II receptor blockers in frail patients with heart failure with preserved ejection fraction. ESC Heart Failure. [DOI: 10.1002/ehf2.13873] [Reference Citation Analysis]
19 Yu H, Xu Z, Qu G, Wang H, Lin L, Li X, Xie X, Lei Y, He X, Chen Y, Li Y. Hypoxic Preconditioning Enhances the Efficacy of Mesenchymal Stem Cells-Derived Conditioned Medium in Switching Microglia toward Anti-inflammatory Polarization in Ischemia/Reperfusion. Cell Mol Neurobiol 2021;41:505-24. [PMID: 32424775 DOI: 10.1007/s10571-020-00868-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Salmon T, Essa H, Tajik B, Isanejad M, Akpan A, Sankaranarayanan R. The Impact of Frailty and Comorbidities on Heart Failure Outcomes. Card Fail Rev 2022;8:e07. [DOI: 10.15420/cfr.2021.29] [Reference Citation Analysis]
21 Kohsaka S, Sandhu AT, Parizo JT, Shoji S, Kumamamru H, Heidenreich PA. Association of Diagnostic Coding-Based Frailty and Outcomes in Patients With Heart Failure: A Report From the Veterans Affairs Health System. J Am Heart Assoc 2020;9:e016502. [PMID: 33283587 DOI: 10.1161/JAHA.120.016502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Ofori-Asenso R, Chin KL, Sahle BW, Mazidi M, Zullo AR, Liew D. Frailty Confers High Mortality Risk across Different Populations: Evidence from an Overview of Systematic Reviews and Meta-Analyses. Geriatrics (Basel) 2020;5:E17. [PMID: 32178338 DOI: 10.3390/geriatrics5010017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Liperoti R, Vetrano DL, Palmer K, Targowski T, Cipriani MC, Lo Monaco MR, Giovannini S, Acampora N, Villani ER, Bernabei R, Onder G; ADVANTAGE JA WP4 group. Association between frailty and ischemic heart disease: a systematic review and meta-analysis. BMC Geriatr 2021;21:357. [PMID: 34112104 DOI: 10.1186/s12877-021-02304-9] [Reference Citation Analysis]
24 Sunaga A, Hikoso S, Yamada T, Yasumura Y, Uematsu M, Tamaki S, Abe H, Nakagawa Y, Higuchi Y, Fuji H, Mano T, Kurakami H, Yamada T, Kitamura T, Sato T, Oeun B, Kida H, Kojima T, Sotomi Y, Dohi T, Okada K, Suna S, Mizuno H, Nakatani D, Sakata Y; OCVC-Heart Failure Investigators. Prognostic impact of Clinical Frailty Scale in patients with heart failure with preserved ejection fraction. ESC Heart Fail 2021;8:3316-26. [PMID: 34151546 DOI: 10.1002/ehf2.13482] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Oleynikov VE, Averyanova EV, Oreshkina AA, Burko NV, Barmenkova YA, Golubeva AV, Galimskaya VA. A Multivariate Model to Predict Chronic Heart Failure after Acute ST-Segment Elevation Myocardial Infarction: Preliminary Study. Diagnostics (Basel) 2021;11:1925. [PMID: 34679623 DOI: 10.3390/diagnostics11101925] [Reference Citation Analysis]
26 Broussier A, David JP, Kharoubi M, Oghina S, Segaux L, Teiger E, Laurent M, Fromentin I, Bastuji-Garin S, Damy T. Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg. J Clin Med 2021;10:3415. [PMID: 34362197 DOI: 10.3390/jcm10153415] [Reference Citation Analysis]
27 Fuentes-Abolafio IJ, Stubbs B, Pérez-Belmonte LM, Bernal-López MR, Gómez-Huelgas R, Cuesta-Vargas AI. Physical functional performance and prognosis in patients with heart failure: a systematic review and meta-analysis. BMC Cardiovasc Disord 2020;20:512. [PMID: 33297975 DOI: 10.1186/s12872-020-01725-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Camafort M, Formiga F. [Sacubitril-valsartan should also be the first choice to be evaluated in the elderly patient with heart failure with reduced ejection fraction]. Rev Esp Geriatr Gerontol 2021;56:67-8. [PMID: 33526274 DOI: 10.1016/j.regg.2020.12.006] [Reference Citation Analysis]
29 Yang X, Lupón J, Vidán MT, Ferguson C, Gastelurrutia P, Newton PJ, Macdonald PS, Bueno H, Bayés-Genís A, Woo J, Fung E. Impact of Frailty on Mortality and Hospitalization in Chronic Heart Failure: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2018;7:e008251. [PMID: 30571603 DOI: 10.1161/JAHA.117.008251] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
30 Son Y, Kim S, Lee W, Shin SY, Won H, Cho JH, Kim HM, Hong J, Choi J. Prevalence and factors associated with pre‐frailty and frailty among Korean older adults with heart failure. Journal of Advanced Nursing. [DOI: 10.1111/jan.15248] [Reference Citation Analysis]
31 Pandey A, Kitzman D, Whellan DJ, Duncan PW, Mentz RJ, Pastva AM, Nelson MB, Upadhya B, Chen H, Reeves GR. Frailty Among Older Decompensated Heart Failure Patients: Prevalence, Association With Patient-Centered Outcomes, and Efficient Detection Methods. JACC Heart Fail 2019;7:1079-88. [PMID: 31779931 DOI: 10.1016/j.jchf.2019.10.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
32 Watanabe K, Yoshihisa A, Sato Y, Hotsuki Y, Anzai F, Ichijo Y, Kimishima Y, Yokokawa T, Misaka T, Sato T, Kaneshiro T, Oikawa M, Kobayashi A, Takeishi Y. Cardio-Ankle Vascular Index Reflects Impaired Exercise Capacity and Predicts Adverse Prognosis in Patients With Heart Failure. Front Cardiovasc Med 2021;8:631807. [PMID: 33869301 DOI: 10.3389/fcvm.2021.631807] [Reference Citation Analysis]
33 Maeda D, Matsue Y, Kagiyama N, Jujo K, Saito K, Kamiya K, Saito H, Ogasahara Y, Maekawa E, Konishi M, Kitai T, Iwata K, Wada H, Hiki M, Dotare T, Sunayama T, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Wakaume K, Oka K, Momomura SI, Minamino T. Sex differences in the prevalence and prognostic impact of physical frailty and sarcopenia among older patients with heart failure. Nutr Metab Cardiovasc Dis 2021:S0939-4753(21)00510-X. [PMID: 34893406 DOI: 10.1016/j.numecd.2021.10.012] [Reference Citation Analysis]
34 Uchmanowicz I, Lee CS, Vitale C, Manulik S, Denfeld QE, Uchmanowicz B, Rosińczuk J, Drozd M, Jaroch J, Jankowska EA. Frailty and the risk of all-cause mortality and hospitalization in chronic heart failure: a meta-analysis. ESC Heart Fail 2020. [PMID: 32955168 DOI: 10.1002/ehf2.12827] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
35 Tanaka S, Jung H, Tanaka R. Identifying Target Values of Body Composition for Preventing Frailty: A Descriptive Study in Older Adults. Gerontology and Geriatric Medicine 2022;8:233372142110644. [DOI: 10.1177/23337214211064493] [Reference Citation Analysis]
36 Ge M, Zhang Y, Zhao W, Yue J, Hou L, Xia X, Zhao Y, Liu X, Dong B, Ge N. Prevalence and Its Associated Factors of Physical Frailty and Cognitive Impairment: Findings from the West China Health and Aging Trend Study (WCHAT). J Nutr Health Aging 2020;24:525-33. [PMID: 32346692 DOI: 10.1007/s12603-020-1363-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
37 Kitzman DW, Whellan DJ, Duncan P, Pastva AM, Mentz RJ, Reeves GR, Nelson MB, Chen H, Upadhya B, Reed SD, Espeland MA, Hewston L, O'Connor CM. Physical Rehabilitation for Older Patients Hospitalized for Heart Failure. N Engl J Med 2021;385:203-16. [PMID: 33999544 DOI: 10.1056/NEJMoa2026141] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 12.0] [Reference Citation Analysis]
38 Maeda D, Kagiyama N, Jujo K, Saito K, Kamiya K, Saito H, Ogasahara Y, Maekawa E, Konishi M, Kitai T, Iwata K, Wada H, Hiki M, Dotare T, Sunayama T, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Yonezawa R, Oka K, Momomura SI, Matsue Y. Aspartate aminotransferase to alanine aminotransferase ratio is associated with frailty and mortality in older patients with heart failure. Sci Rep 2021;11:11957. [PMID: 34099767 DOI: 10.1038/s41598-021-91368-z] [Reference Citation Analysis]
39 Tournas G, Kourek C, Mantzaraki V, Georgiopoulos G, Pantos C, Toumanidis S, Briasoulis A, Paraskevaidis I. Assessment of Frailty and Related Outcomes in Older Patients with Heart Failure: a Cohort Study. Hellenic Journal of Cardiology 2022. [DOI: 10.1016/j.hjc.2022.04.004] [Reference Citation Analysis]
40 Chi J, Chen F, Zhang J, Niu X, Tao H, Ruan H, Jin L, Wang Y. Frailty is associated with 90-day unplanned readmissions and death in patients with heart failure: A longitudinal study in China. Heart Lung 2022;53:25-31. [PMID: 35121488 DOI: 10.1016/j.hrtlng.2022.01.007] [Reference Citation Analysis]
41 Itagaki T, Ebisawa S, Otagiri K, Kato T, Miura T, Kanzaki Y, Abe N, Yokota D, Yanagisawa T, Senda K, Okina Y, Wakabayashi T, Oyama Y, Karube K, Machida K, Takeuchi T, Saigusa T, Motoki H, Kitabayashi H, Kuwahara K. Body composition and mortality in patients undergoing endovascular treatment for peripheral artery disease. Heart Vessels 2021. [PMID: 34097103 DOI: 10.1007/s00380-021-01883-2] [Reference Citation Analysis]
42 Tanaka S, Yamashita M, Saito H, Kamiya K, Maeda D, Konishi M, Matsue Y. Multidomain Frailty in Heart Failure: Current Status and Future Perspectives. Curr Heart Fail Rep 2021;18:107-20. [PMID: 33835397 DOI: 10.1007/s11897-021-00513-2] [Reference Citation Analysis]
43 Shrauner W, Lord EM, Nguyen XT, Song RJ, Galloway A, Gagnon DR, Driver JA, Gaziano JM, Wilson PWF, Djousse L, Cho K, Orkaby AR. Frailty and cardiovascular mortality in more than 3 million US Veterans. Eur Heart J 2021:ehab850. [PMID: 34907422 DOI: 10.1093/eurheartj/ehab850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]